Rowland Chang is a Rheumatology/Immunology physician affiliated with Northwestern University. OpenAlex indexes 189 publications with 10,559 citations (h-index 55); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
355 E Erie St
Chicago, IL 606113167
Telephone
312-238-1000Provider last certified this registry record 22 Apr 2022.
Clinical trials
- Computer-guided Action Planning to Support Physical Activity (CAPPA) for Employees With Chronic Knee Symptoms
Sponsor: Marquette University
- Improving Motivation for Physical Activity in Arthritis Clinical Trial
Sponsor: Northwestern University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
53.7%Folate Analog Metabolic Inhibitor29.7%Methotrexate87%Methotrexate Sodium13%Part D<11 patientsTNF inhibitor24%Enbrel43%Enbrel Sureclick31%Humira Pen27%Part D<11 patientsMetabolism & gastrointestinal
21.1%Corticosteroid13.7%Prednisone100%Part D<11 patientsAminosalicylate7.3%Sulfasalazine Dr52%Sulfasalazine48%Part D<11 patientsNervous system
16.3%Nonsteroidal Anti-inflammatory Drug16.3%Meloxicam100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
7 NIH research awards on record, funded 1998–2021 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Relationship of knee pain to time in moderate and light physical activities: Data from Osteoarthritis Initiative
Seminars in Arthritis and Rheumatism
2017 - Esophageal dilatation and interstitial lung disease in systemic sclerosis: A cross-sectional study
Seminars in Arthritis and Rheumatism
2016 - Physical Activity Minimum Threshold Predicting Improved Function in Adults With Lower‐Extremity Symptoms
Arthritis Care & Research
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Clyde Yancy, MD
Northwestern University
Philip Greenland, MD
Northwestern University
Peter Kahrilas, MD
Northwestern University
Philip Gorelick, MD
Northwestern University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”